YY1/Asprosin/PFKP Axis Regulates Glycolytic Metabolic and Exacerbates Pathological Cardiac Hypertrophy
This study aims to elucidate the key drivers underlying abnormal cardiac energy metabolism in pathological myocardial hypertrophy and to identify potential therapeutic targets and early diagnostic biomarkers.